Sakura Research
linking the dots
Applovin Corp: A cash-poor company with a distressed balance sheet and questionable asset quality, not paying income taxes. The financials of its overseas subsidiaries are suspect, exhibiting signs of revenue round-tripping and fictitious revenues. Additionally, the company has sketchy products and a shallow AI team. (NASDAQ:APP)
Feb 25
iFast Corp: Public Accounting Questions for iFAST and its Auditor, KPMG (SGX:AIY)
Feb 20
Raffles Medical Group: Letter to SGX, SIAS, and The Auditor, KPMG LLP (SGX:BSL)
Dec 3
Raffles Medical Group: Letter to the Board (SGX:BSL)
Nov 27
Raffles Medical: Superior revenue-generating prime Singapore properties at absurdly under-appraised values. Mark-to-market with fair value gains of S$774m
Nov 27
Raffles Medical Group: Call for Strategic Review, Part II – Greater China Investments (SGX:BSL)
Nov 27
Raffles Medical Group: Call for Strategic Review, Part III – Insurance (SGX:BSL)
Nov 27
iFast Corp: Accounting antics continue following Q3 2024 results, increasing balance sheet stress
Oct 29
iFast Corp: Pulling a Fast One — Questionable Accounting Practices, Misleading Investors, and Fraud
Oct 13
DHLU: Our Tactical SREIT Pick Due to Strengthening Yen
Sep 16
iFast GLOBAL BANK: Loss-making asset underreports its losses. No foreseeable profits. Continuous equity infusions. Ineffective management.
Sep 16
iFast Corp: Our Response to Business Times Article
Sep 5
UOB-Kay Hian – Cash-rich balance sheet, great cash flow yields and high dividend rate, and a prime target for privatisation/take over (SGX:U10)
Aug 19
iFast Corp: Accounting Questions (SGX:AIY)
Aug 19
iFast Corp: Analyst Misconceptions (SGX:AIY)
Aug 19
iFast Corp: Stagnating core business after the pandemic bump, inability to generate meaningful free cash flows, and increasing financial stress (SGX:AIY)
Aug 19
Disclaimers. Terms &Â Conditions.
Aug 15